These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28621164)

  • 21. Elevated soluble epidermal growth factor receptor level in pituitary adenoma and carcinoma.
    Kong YG; Ren ZY; Su CB; Wang RZ; Ma WB; Lian W
    Chin Med Sci J; 2004 Sep; 19(3):199-202. PubMed ID: 15506648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic and predictive impact of soluble epidermal growth factor receptor (sEGFR) protein in the serum of patients treated with chemotherapy for metastatic breast cancer.
    Müller V; Witzel I; Pantel K; Krenkel S; Lück HJ; Neumann R; Keller T; Dittmer J; Jänicke F; Thomssen C
    Anticancer Res; 2006; 26(2B):1479-87. PubMed ID: 16619561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum irisin levels in patients with psoriasis.
    Baran A; Myśliwiec H; Kiluk P; Świderska M; Flisiak I
    J Dermatolog Treat; 2017 Jun; 28(4):304-308. PubMed ID: 27786588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indirubin, an acting component of indigo naturalis, inhibits EGFR activation and EGF-induced CDC25B gene expression in epidermal keratinocytes.
    Hsieh WL; Lin YK; Tsai CN; Wang TM; Chen TY; Pang JH
    J Dermatol Sci; 2012 Aug; 67(2):140-6. PubMed ID: 22721997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multiparameter flow cytometric analysis of the effect of bexarotene on the epidermis of the psoriatic lesion.
    Franssen ME; Smit JV; Van Erp PE; Van De Kerkhof PC
    Br J Dermatol; 2003 Sep; 149(3):506-12. PubMed ID: 14510982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two EGF molecules contribute additively to stabilization of the EGFR dimer.
    Lemmon MA; Bu Z; Ladbury JE; Zhou M; Pinchasi D; Lax I; Engelman DM; Schlessinger J
    EMBO J; 1997 Jan; 16(2):281-94. PubMed ID: 9029149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of personalized medication training in improving efficacy and adherence to a topical therapy in psoriatic patients.
    Caldarola G; De Simone C; Moretta G; Poscia A; Peris K
    J Dermatolog Treat; 2017 Dec; 28(8):722-725. PubMed ID: 28488449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomolecular index of therapeutic efficacy in psoriasis treated with anti-TNF-α agents.
    Bianchi L; Costanza G; Campione E; Ruzzetti M; Di Stefani A; Diluvio L; Giardina E; Cascella R; Cordiali-Fei P; Bonifati C; Chiricozzi A; Novelli G; Ensoli F; Orlandi A
    G Ital Dermatol Venereol; 2018 Jun; 153(3):316-325. PubMed ID: 27627098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical calcipotriol for psoriasis--an immunohistologic study.
    Mozzanica N; Cattaneo A; Schmitt E; Diotti R; Finzi AF
    Acta Derm Venereol Suppl (Stockh); 1994; 186():171-2. PubMed ID: 7915481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proliferation is the main epidermal target in the treatment of psoriatic plaques with once daily application of tacalcitol ointment.
    Castelijns FA; Gerritsen MJ; van Vlijmen-Willems IM; van Erp PJ; van de Kerkhof PC
    Acta Derm Venereol; 1999 Mar; 79(2):111-4. PubMed ID: 10228627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations.
    Flisiak I; Zaniewski P; Rogalska-Taranta M; Chodynicka B
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):302-7. PubMed ID: 21418334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozole.
    Lafky JM; Baron AT; Cora EM; Hillman DW; Suman VJ; Perez EA; Ingle JN; Maihle NJ
    Cancer Res; 2005 Apr; 65(8):3059-62. PubMed ID: 15833834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum and correspondent tissue measurements of epidermal growth factor (EGF) and epidermal growth factor receptor (EGF-R). Clinical relevance in pancreatic cancer and chronic pancreatitis.
    Birk D; Gansauge F; Gansauge S; Formentini A; Lucht A; Beger HG
    Int J Pancreatol; 1999 Apr; 25(2):89-96. PubMed ID: 10360220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
    Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
    Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonism of epidermal growth factor receptor tyrosine kinase ameliorates the psoriatic phenotype in organ-cultured skin.
    Varani J; Lateef H; Fay K; Elder JT
    Skin Pharmacol Physiol; 2005; 18(3):123-31. PubMed ID: 15897684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human psoriatic skin in organ culture: comparison with normal skin exposed to exogenous growth factors and effects of an antibody to the EGF receptor.
    Varani J; Kang S; Stoll S; Elder JT
    Pathobiology; 1998; 66(6):253-9. PubMed ID: 9769471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EGF receptor expression and growth of psoriatic and normal human keratinocytes are modulated by 1.25 (OH)2-vitamin D3 ex vivo.
    Boisseau-Garsaud AM; Donatien P; Margerin C; Taïeb A
    Arch Dermatol Res; 1996 Jul; 288(8):453-7. PubMed ID: 8844124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comparative Study to Evaluate Epidermal Barrier Integrity of Psoriasis Patients Treated With Calcipotriene/Betamethasone Topical Suspension Versus Betamethasone Dipropionate 0.05% Lotion.
    Hashim PW; Nia JK; Terrano D; Goldenberg G; Kircik LH
    J Drugs Dermatol; 2017 Aug; 16(8):747-752. PubMed ID: 28809989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.